Growth Metrics

CytomX Therapeutics (CTMX) Amortizatization of Intangibles (2016 - 2025)

CytomX Therapeutics' Amortizatization of Intangibles history spans 12 years, with the latest figure at $37000.0 for Q4 2025.

  • For Q4 2025, Amortizatization of Intangibles rose 100.85% year-over-year to $37000.0; the TTM value through Dec 2025 reached $146000.0, changed 0.0%, while the annual FY2025 figure was $146000.0, 0.0% changed from the prior year.
  • Amortizatization of Intangibles reached $37000.0 in Q4 2025 per CTMX's latest filing, up from $36000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $4.5 million in Q3 2024 to a low of -$4.4 million in Q4 2024.
  • Average Amortizatization of Intangibles over 5 years is $29500.0, with a median of $26500.0 recorded in 2022.
  • The largest YoY upside for Amortizatization of Intangibles was 12263.89% in 2024 against a maximum downside of 48544.44% in 2024.
  • A 5-year view of Amortizatization of Intangibles shows it stood at $433000.0 in 2021, then crashed by 98.85% to $5000.0 in 2022, then crashed by 280.0% to -$9000.0 in 2023, then plummeted by 48544.44% to -$4.4 million in 2024, then skyrocketed by 100.85% to $37000.0 in 2025.
  • Per Business Quant, the three most recent readings for CTMX's Amortizatization of Intangibles are $37000.0 (Q4 2025), $36000.0 (Q3 2025), and $37000.0 (Q2 2025).